IP Library › Granted Patent US 12,567,496
Granted Patent B2
US 12,567,496 · App. 18/077,540 · Granted Mar 3, 2026

Method and apparatus for displaying and analyzing medical scan images

Inventors: David Arrowsmith (Oxford, GB); Quentin Chometon (Oxford, GB); Timor Kadir (Oxford, GB)
Assignee: Optellum Limited
G16H30/20G06T7/0012G16H30/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,567,496
App. No.
18/077,540
Granted
Mar 3, 2026
Kind
B2
Abstract

A display system for a computer aided lung cancer diagnosis system is described. The system comprises: a user interface which comprises: a patient information display wherein the patient information comprises one or more of: patient name, patient age, patient sex, smoking history, disease history, and current patient status; an image display for displaying at least one of a selected plurality of medical images acquired at different times and an associated image report; and a patient timeline display for providing a visual display of patient events over a set time period; and a proxy data store to store the selected plurality of medical images, wherein the selected plurality of medical images are provided from an external archive and are pre-selected to comprise one or more relevant archive images, and exclude irrelevant archive images.

Claims (25)

1 . A display system for a computer aided lung image review system comprising:

a user interface which comprises:

a patient information display wherein the patient information comprises one or more of: patient name, patient age, patient sex, smoking history, disease history, and current patient status;

an image display for displaying at least one of a selected plurality of medical images acquired at different times and an associated image report; and

a patient timeline display for providing a visual display of patient events over a set time period;

a proxy data store to store the selected plurality of medical images;

an analysis circuit for analysing at least one displayed image, to perform at least one of: determining and marking the location of one or more features on the image; determining a lung cancer risk score for one or more of the marked features on the image, where the analysis circuit is configured to include one or more manual annotations from a user to manually mark the location of one of more features on the image, wherein the manual marking of the image feature is done by selecting an image feature in the image display, wherein the manual marking of the image feature triggers the computation of a disease risk score by the analysis circuit; and

wherein the selected plurality of medical images are provided from an external archive and are pre-selected to comprise one or more relevant archive images, and exclude irrelevant archive images.

2 . A display system as claimed in claim 1 , wherein the user interface further comprises:

a lung cancer risk score display; and

a clinical summary display.

3 . A display system as claimed in claim 1 , wherein the plurality of medical images are CT images.

4 . A display system as claimed in claim 3 , wherein the plurality of medical images are sets of image slices forming one or more image stacks, and a user is able to select images from the image stacks to be provided from the external archive to the proxy data store.

5 . A display system as claimed in claim 4 , wherein the image display prioritizes the download from the proxy data store of those image slices in the proximity of the image location being viewed by the system user.

6 . A display system as claimed in claim 1 , wherein the patient timeline display is reviewed, and patient events that are irrelevant to a lung cancer diagnosis are removed from the patient timeline display and archived.

7 . A display system as claimed in claim 6 , wherein the irrelevant events are archived either automatically, or manually after review of the patient timeline by a system user.

8 . A display system as claimed in claim 7 , wherein a study in the patient timeline display can be marked as the baseline study of a patient.

9 . A display system as claimed in claim 1 , wherein the marked feature is a lung nodule.

10 . A display system as claimed in claim 1 , wherein the analysis circuit is further configured to allow a user to navigate directly to a marked location on the image.

11 . A display system as claimed in claim 10 , wherein at least two images are displayed with marked locations, and the analysis circuit synchronises the navigation to the marked location on the at least two images.

12 . A display system as claimed in claim 10 , wherein the analysis circuit enables a system user to edit information about the marked location on the image.

13 . A display system as claimed in claim 1 , wherein the patient information timeline can be updated with new information.

14 . A display system as claimed in claim 13 , wherein the patient information timeline is updated manually or automatically.

15 . A display system as claimed in claim 1 , wherein further images are provided from the external archive to update the available images for display.

16 . A display system as claimed in claim 1 , wherein the patient timeline and the image display are linked so that timeline events relative to the displayed image are highlighted on the patient timeline display.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2023
From: ARROWSMITH, DAVID; CHOMETON, QUENTIN; KADIR, TIMOR
To: LIMITED, OPTELLUM
Reel/Frame 062255/0180 →
Continuity (1)
Related Publication 20240194323A1 · Jun 13, 2024
References Cited (25)
US 8732601B2 · Licato · 2014 [cited by applicant]
US 10297352B2 · Sakagawa et al. · 2019 [cited by applicant]
US 10803579B2 · Song et al. · 2020 [cited by applicant]
US 20030095692A1 · Mundy · 2003 [cited by examiner]
US 20180341751A1 · Lyman · 2018 [cited by applicant]
US 20200118164A1 · DeFrank · 2020 [cited by examiner]
US 20210090694A1 · Colley · 2021 [cited by examiner]
US 20230051982A1 · Sasidharan · 2023 [cited by examiner]
US 20230197248A1 · Cambray Roma · 2023 [cited by examiner]
US 20230274809A1 · Dimitrova · 2023 [cited by examiner]
US 20230367784A1 · Jacobs · 2023 [cited by examiner]
US 20230410223A1 · Dobson · 2023 [cited by examiner]
An Appraisal of Nodule Diagnosis for Lung Cancer in CT Images. Zhang G et al. Journal of Medical Systems (2019) 43: 181. https://doi.org/10.1007/s10916-019-1327-0. [cited by applicant]
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. Peter Goldstraw et al. Journal of Thoracic Oncology… [cited by applicant]
Reduced lung-cancer mortality with low-dose computed tomographic screening. Aberle DR, et al. N Engl J Med. 2011;365(5):395-409. Epub Jul. 1, 2011. PubMed PMID: 21714641. [cited by applicant]
Nelson Study Shows CT Screening for Nodule Volume Management Reduces Lung Cancer Mortality by 26 Percent in Men. Koning HJD. Toronto, Canada: IASLC; 2018. [cited by applicant]
Recent Trends in the Identification of Incidental Pulmonary Nodules. Michael K. Gould et al. American Journal of Respiratory and Critical Care Medicine vol. 192 No. 10; 2015. [cited by applicant]
British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Callister ME et al; British Thoracic Society Pulmonary Nodule Guideline Development Group; British Thoracic Society Standard… [cited by applicant]
Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. MacMahon, Heber, et al. Radiology 284.1 (2017): 228-243. [cited by applicant]
Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed. Gould MK et al. American College of Chest Physicians evidence-based clinical practice guidelines… [cited by applicant]
Development of a Risk Prediction Model to Estimate the Probability of Malignancy in Pulmonary Nodules Being Considered for Biopsy. Reid M, et al. Chest. 2019;156(2):367-75. Epub Apr. 4, 2019. doi: 10.1016/j.chest.2019.0… [cited by applicant]
Invasive modalities for the diagnosis of peripheral lung nodules. Expert Review of Respiratory Medicine. Kalanjeri S et al. 2021 https://doi.org/10.1080/17476348.2021.1913059. [cited by applicant]
Pneumothorax after transthoracic needle biopsy of lung lesions under CT guidance. Boskovic T et al. Journal of thoracic disease, 6 Suppl 1(Suppl 1), S99-S107. https://doi.org/10.3978/j.issn.2072-1439.2013.12.08 (2014). [cited by applicant]
No stone unturned: Nodule Net, an intervention to reduce loss to follow-up of lung nodules. Weinstock TG et al. Respiratory Medicine 157 (2019) 49-51. https://doi.org/10.1016/j.rmed.2019.09.003. [cited by applicant]
Nodule net: A prospective safety net program to reduce loss to follow-up and increase early detection of lung cancer. Harpreet Singh et al. DOI: 10.1200/JCO.2021.39.15_suppl. 1564 Journal of Clinical Oncology 39, No. 15… [cited by applicant]